Vitrectomy with Silicone Oil or Sulfur Hexafluoride Gas in Eyes with Severe Proliferative Vitreoretinopathy: Results of a Randomized Clinical Trial: Silicone Study Report 1

Archives of Ophthalmology

Volumn 110, Issue 6, 1992, Pages 770-779

  Lean, John S ^a   Boone, Donna C ^a   Azen, Stanley P ^a   Lai, Mei Ying ^a   Linton, Kathryn L P ^a   McCuen, Brooks W ^a   Ryan, Stephen J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

OCTAFLUOROPROPANE; SILICONE OIL; SULFUR HEXAFLUORIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GAS; HUMAN; INTRAOCULAR PRESSURE; KERATOPATHY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REOPERATION; RETINA DETACHMENT; RETINA MACULA LUTEA; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY;

ADULT; AGED; AGED, 80 AND OVER; COMPARATIVE STUDY; EYE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETINAL DETACHMENT; RETINAL DISEASES; SILICONE OILS; SULFUR HEXAFLUORIDE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 0026717102     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopht.1992.01080180042027     Document Type: Article

References (14)

1. Azen SP, Boone DC, Barlow W, et al. Methods, statistical features and baseline results of a standardized, multicentered ophthalmologic surgical trial: the Silicone Study. Controlled Clin Trials. 1991;12:438–455.
2. Ando F. Intraocular hypertension resulting from pupillary block by silicone oil. Am J Ophthalmol. 1985;99:87–88.
3. Blumenkranz M, Gardner T, Blankenship G. Fluid-gas exchange and photocoagulation after vitrectomy. Arch Ophthalmol. 1986;104:291–296.
4. Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1983;90:121.
5. Lean JS, Stern WH, Irvine AR, Azen SP, The Silicone Study Group. Classification and documentation of pre-surgical proliferative vitreoretinopathy. Ophthalmology. 1989;96:765–771.
6. The Diabetic Retinopathy Study Research Group. Report 6: design, methods, and baseline results. Invest Ophthalmol Vis Sci. 1981;21:149–209.
7. Azen SP, Irvine AR, Davis M, et al. The validity and reliability of photographic documentation of proliferative vitreoretinopathy. Ophthalmology. 1989;96:352–357.
8. Barlow W, Azen SP, The Silicone Study Group. The effect of therapeutic treatment crossovers on the power of a clinical trial. Controlled Clin Trials. 1990;11:314–326.
9. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons Inc; 1989.
10. Chan C, Okun E. The question of ocular tolerance to intravitreal liquid silicone. Ophthalmology. 1986;93:651–659.
11. Van Horn DL, Edelhouser HF, Aaberg TM, Peterson JH. In vivo effects of air and sulfur hexafluoride gas on rabbit corneal endothelium. Invest Ophthalmol Vis Sci. 1972;11:1028–1036.
12. Casswell AG, Gregor ZJ. Silicone oil removal, II: operative and postoperative complications. Br J Ophthalmol. 1987;71:898–902.
13. McCuen BW II, de Juan E Jr, Landers MB III, MacHemer R. Silicone oil in vitreoretinal surgery, II: results and complications. Retina. 1985;5:198–205.
14. Zivojnovic R, Mertens DAE, Perkamp E. Das flssige silikon in der amotiochirugie, II: bericht über 280 fälleweitere entwicklung der technik. Klin Monatsbl Augenheilkd. 1982;181:444–452.